Liquid biopsy has emerged as a promising non-invasive approach for detecting, monitoring
diseases, and predicting their recurrence. However, the effective utilization of liquid biopsy …

Cancer is a complex and heterogeneous disease that poses a significant threat to global
health. Early diagnosis and treatment are critical for improving patient outcomes, and the …

Treatments for cancer patients are becoming increasingly complex, and there is a growing
desire from clinicians and patients for biomarkers that can account for this complexity to …

Precision oncology aims to tailor clinical decisions specifically to patients with the objective
of improving treatment outcomes. This can be achieved by leveraging omics information for …

Despite significant advances in cancer diagnosis and treatment, cancer remains one of the
major causes of mortality worldwide. Current challenges in cancer management include …

Aliquid biopsy is a simple noninvasive alternative to tissue biopsies in which a body fluid
specimen is obtained for detailed laboratory analyses. Tissue biopsy has been used to …

Simple Summary Liquid biopsies provide a non-invasive means to diagnose and profile
tumors when tissue is not available. Sequence-based analysis of cell-free DNA (cfDNA) is …

Abstract Motivation Cell-free DNA (cfDNA) is gaining substantial attention from both
biological and clinical fields as a promising marker for liquid biopsy. Many aspects of …

Liquid biopsy (LB) has emerged as a highly promising and non-invasive diagnostic
approach, particularly in the field of oncology, and has garnered interest in various medical …

Alterations in DNAs could not reveal what happened in proteins. The accumulated
alterations of DNAs would change the manifestation of proteins. Therefore, as is the case in …